Scynexis (SCYX) Cost of Revenue (2013 - 2023)
Scynexis' (SCYX) quarterly Cost of Revenue came in at $14.7 million in Q4 2023, up 7391.84% YoY from $196000.0 in Q4 2022, and up 3774.41% on a QoQ basis from $379000.0 in Q3 2023.
Scynexis (SCYX) Cost of Revenue (2013 - 2023) Analysis & Trends
Scynexis (SCYX) has 6 years of Cost of Revenue data on file, last reported at $14.7 million in Q4 2023.
- Quarterly Cost of Revenue rose 7391.84% year-over-year to $14.7 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $14.7 million (up 1190.33% YoY) and the FY2023 annual result came in at $15.6 million, up 2387.9% from the prior year.
- Cost of Revenue advanced to $14.7 million in Q4 2023, from $379000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $14.7 million in Q4 2023 to a low of $99000.0 in Q1 2022.
- A 3-year average of $1.7 million and a median of $178000.0 in 2021 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue advanced 17.37% — and 2023, when it surged 7391.84%.
- Tracing SCYX's Cost of Revenue over 3 years: stood at $167000.0 in 2021, then climbed by 17.37% to $196000.0 in 2022, then surged by 7391.84% to $14.7 million in 2023.
- The last three Cost of Revenue figures came in at $14.7 million (Q4 2023), $379000.0 (Q3 2023), and $426000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Scynexis | 60.95 Mn | -53.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 14.68 Mn |
| Dec 31, 2023 | 14.68 Mn |
| Sep 30, 2023 | 379,000.00 |
| Sep 30, 2023 | 379,000.00 |
| Jun 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 426,000.00 |
| Mar 31, 2023 | 137,000.00 |
| Mar 31, 2023 | 137,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Sep 30, 2021 | 145,000.00 |
| Sep 30, 2021 | 145,000.00 |